Related Experiment Videos

Multiple opioid ligands and receptors in the control of nociception

V Höllt, P Sanchez-Blazquez, J Garzon

    Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
    |February 19, 1985
    PubMed

    Insights

    This study reveals that opioid receptors in the mouse brain, specifically epsilon-receptors, mediate pain relief (antinociception). Beta-endorphin and proenkephalin A peptides are the key natural substances activating these pain-controlling receptors.

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Pain Research

    Background:

    • Endogenous opioid peptides and receptors play a critical role in pain perception (nociception).
    • Understanding these systems is key to developing novel pain management strategies.

    Purpose of the Study:

    • To characterize the role of endogenous opioid peptides and receptors in nociception.
    • To identify the specific opioid receptors and their ligands involved in central antinociception.

    Main Methods:

    • Review of recent data on opioid peptides and receptors in nociception.
    • Analysis of intracerebroventricular (ICV) opioid injections in mouse models.
    • Comparison of brain receptors with those found in the rat vas deferens.

    Main Results:

    • Opioid-induced antinociception in the mouse brain is mediated by specific receptors.
    • These receptors are similar to those involved in the inhibitory action of opioids on the rat vas deferens (putative epsilon-receptors).
    • Beta-endorphin and peptides from proenkephalin A are identified as endogenous ligands for these epsilon-receptors.

    Conclusions:

    • The study elucidates the central mechanisms of opioid-mediated pain relief.
    • Identifies a specific receptor subtype (epsilon-receptors) and its endogenous ligands involved in antinociception.
    • Provides a foundation for targeted therapeutic interventions in pain management.

    Related Concept Videos